Engineered thoracic spinal cord organoids for transplantation after spinal cord injury
8.0
来源：
Nature
关键字：
optogenetics
发布时间：
2025-10-24 19:37
摘要：
Engineered thoracic spinal cord organoids (enTsOrg) have been developed to enhance recovery from spinal cord injuries. These organoids, derived from induced pluripotent stem cells, replicate the anatomical and functional characteristics of the thoracic spinal cord, demonstrating significant improvements in motor function recovery in rodent models. The study emphasizes the importance of regional specificity and neuronal maturation in organoid transplantation, suggesting a promising avenue for innovative therapies in spinal cord repair.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
1.0
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.5
market_value_relevance
1.0
team_institution_background
0.5
technical_barrier_competition
1.0
关键证据
Transplantation of enTsOrg significantly restored hind-limb motor function in rodent models of spinal cord injury.
The organoids exhibited advanced maturation and functionalization of critical neuronal subtypes.
The study highlights the potential for organoid technology in developing targeted therapies for spinal cord injuries.
真实性检查
否
AI评分总结
Engineered thoracic spinal cord organoids (enTsOrg) have been developed to enhance recovery from spinal cord injuries. These organoids, derived from induced pluripotent stem cells, replicate the anatomical and functional characteristics of the thoracic spinal cord, demonstrating significant improvements in motor function recovery in rodent models. The study emphasizes the importance of regional specificity and neuronal maturation in organoid transplantation, suggesting a promising avenue for innovative therapies in spinal cord repair.